Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CITIGROUP INC (C)

  • SEC News
  • April 20, 2026, 11:31 UTC
  • 2
  • 0 comments

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010216 <b>Size:</b> 883 KB

Comment Full text

CITIGROUP INC (C)

  • SEC News
  • April 20, 2026, 11:31 UTC
  • 2
  • 0 comments

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010217 <b>Size:</b> 870 KB

Comment Full text

FEO HOSPITALITY ASSET MANAGEMENT PTE. LTD. (Q5T)

  • SEC News
  • April 20, 2026, 11:30 UTC
  • 2
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR - VIVIENNE LIM HUI BIAN

Comment Full text

CITIGROUP INC (C)

  • SEC News
  • April 20, 2026, 11:30 UTC
  • 2
  • 0 comments

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010215 <b>Size:</b> 883 KB

Comment Full text

Briacell Therapeutics Corp (BCTX)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Market reaction Comment Full text

VolitionRX Limited (VNRX)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Volition Launches rNuQ™ Webshop Broadening Product Range

Market reaction Comment Full text

NEUROGENE INC. (NGNE)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors

Market reaction Comment Full text

PALVELLA THERAPEUTICS, INC. (PVLA)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

Market reaction Comment Full text

BIOGEN INC. (BIIB)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

Market reaction Comment Full text

DRAGONFLY ENERGY HOLDINGS CORP. (DFLI)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Dragonfly Energy Secures Multi-Million Dollar Order from Stevens Transport, Marking a Major Commercial Milestone

Market reaction Comment Full text

BIOGEN INC. (BIIB)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

Market reaction Comment Full text

VOLITIONRX LTD (VNRX)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Volition Launches rNuQ™ Webshop Broadening Product Range

Market reaction Comment Full text

BWX TECHNOLOGIES, INC. (BWXT)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

BWXT Bolsters American Nuclear Manufacturing Capability With Strategic Acquisition

Market reaction Comment Full text

SWVL HOLDINGS CORP (SWVL)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%

Market reaction Comment Full text

WW INTERNATIONAL, INC. (WW)

  • Business News
  • April 20, 2026, 11:30 UTC
  • 2
  • 1 comments

Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

Market reaction Comment Full text
  • Previous
  • 715
  • 716
  • 717
  • 718
  • 719
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250723)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150062)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin